Virios therapeutics to present at the snn network summer virtual conference

Atlanta--(business wire)---- $viri #biotech--virios therapeutics, inc. (nasdaq: viri), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, announced today that greg duncan, chairman and chief executive officer, will present a company overview at the snn network summer virtual conference on august 19, 2021 at 9:00 a.m. et. the presentation will focus on the role of activated viruses triggering a wide range of conditions, including fibromyalg
VIRI Ratings Summary
VIRI Quant Ranking